SCHEMBL845170

SCHEMBL845170

O=C(Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)N3CCCC3)cc2)cc1)[C@@H]1CCCN1C(=O)N1CCCC1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
HTT P42858 2/20 0.47
CNR2 P34972 1/20 0.47
NPC1 O15118 1/20 0.46
ALDH1A1 P00352 3/20 0.46
MAPK1 P28482 2/20 0.46
MAPT P10636 1/20 0.44
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
RHOC P08134 1/20 0.44
RHOA P61586 1/20 0.44
PABPC1 P11940 1/20 0.43
TSHR P16473 1/20 0.43
LMNA P02545 1/20 0.43
EP300 Q09472 1/20 0.43
CREBBP Q92793 1/20 0.43
THRB P10828 1/20 0.42
ALOX12 P18054 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845453 0.90 CNR2 (0.53) CYP2C9CYP2C19HTTCNR2NPC1
SCHEMBL844884 0.83 HTT (0.48) CYP2C9CYP2C19HTTNPC1ALDH1A1
SCHEMBL845258 0.82 MAPK1 (0.60) CYP2C9CYP2C19HTTNPC1ALDH1A1
SCHEMBL845255 0.82 CYP2C9 (0.47) CYP2C9CYP2C19HTTCNR2NPC1
SCHEMBL844890 0.81 KCNH2 (0.51) CYP2C9CYP2C19HTTNPC1ALDH1A1
SCHEMBL844919 0.81 NPC1 (0.54) CYP2C9CYP2C19HTTNPC1ALDH1A1
SCHEMBL845251 0.81 PABPC1 (0.50) CYP2C9CYP2C19HTTNPC1ALDH1A1
SCHEMBL873200 0.81 RHOC (0.48) CYP2C9CYP2C19HTTNPC1ALDH1A1
SCHEMBL845774 0.81 CYP2C19 (0.49) CYP2C9CYP2C19HTTNPC1ALDH1A1
SCHEMBL844894 0.81 CYP2C19 (0.55) CYP2C9CYP2C19HTTNPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed